BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Mecca MM, Fanelli SL, Bartel LC, de Castro CR, Díaz EG, Castro JA. Nifurtimox nitroreductase activity in different cellular fractions from male rat pancreas. Biochemical and ultrastructural alterations. Life Sciences 2007;81:144-52. [DOI: 10.1016/j.lfs.2007.04.033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Davies C, Simonazzi A, Micheloud JF, Ragone PG, Cid AG, Negrette OS, Bermúdez JM, Parada LA. Benznidazole/Poloxamer 407 Solid Dispersion as a New Strategy to Improve the Treatment of Experimental Trypanosoma cruzi Infection. J Parasitol 2020;106:323-33. [PMID: 32369594 DOI: 10.1645/19-80] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Colón IG, González FA, Cordero M, Zayas B, Velez C, Cox O, Kumar A, Alegría AE. Role of the nitro functionality in the DNA binding of 3-nitro-10-methylbenzothiazolo[3,2-a]quinolinium chloride. Chem Res Toxicol 2008;21:1706-15. [PMID: 18759504 DOI: 10.1021/tx800076c] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
3 Urbina JA. Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop 2010;115:55-68. [PMID: 19900395 DOI: 10.1016/j.actatropica.2009.10.023] [Cited by in Crossref: 299] [Cited by in F6Publishing: 286] [Article Influence: 23.0] [Reference Citation Analysis]
4 Bermudez J, Davies C, Simonazzi A, Pablo Real J, Palma S. Current drug therapy and pharmaceutical challenges for Chagas disease. Acta Tropica 2016;156:1-16. [DOI: 10.1016/j.actatropica.2015.12.017] [Cited by in Crossref: 141] [Cited by in F6Publishing: 129] [Article Influence: 23.5] [Reference Citation Analysis]
5 Aguilera-venegas B, Olea-azar C, Norambuena E, Arán VJ, Mendizábal F, Lapier M, Maya JD, Kemmerling U, López-muñoz R. ESR, electrochemical, molecular modeling and biological evaluation of 4-substituted and 1,4-disubstituted 7-nitroquinoxalin-2-ones as potential anti-Trypanosoma cruzi agents. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2011;78:1004-12. [DOI: 10.1016/j.saa.2010.12.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
6 Boiani M, Merlino A, Gerpe A, Porcal W, Croce F, Depaula S, Rodríguez M, Cerecetto H, González M. o -Nitroanilines as major metabolic products of anti- Trypanosoma cruzi 5-phenylethenylbenzofuroxans in microsomal and cytosolic fractions of rat hepatocytes and in whole parasitic cells. Xenobiotica 2009;39:236-48. [DOI: 10.1080/00498250802691535] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
7 Delfín DA, Morgan RE, Zhu X, Werbovetz KA. Redox-active dinitrodiphenylthioethers against Leishmania: synthesis, structure-activity relationships and mechanism of action studies. Bioorg Med Chem 2009;17:820-9. [PMID: 19058972 DOI: 10.1016/j.bmc.2008.11.031] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]